Zosano Pharma Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Fremont CA United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2007
NCT00489918
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Zosano Pharma Corporation

Active Ingredients

Drugs in Phase 3 Trials (1)

zolmitriptan (zomig) (4 trials)

Drugs in Phase 2 Trials (1)

teriparatide (2 trials)

Drugs in Phase 1 Trials (2)

glucagon (1 trial)

parathyroid hormone (Natpara) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypoglycemia (Phase 1)

Migraine Disorders (Phase 3)

Osteoporosis (Phase 2)

Osteoporosis, Postmenopausal (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 4